Comité editorial

Editor-in-Chief:

Dr. Benedicto Crespo Facorro, MD, PhD
Chair Professor and Head in the Department of Psychiatry at the University Hospital Virgen del Rocio, University of Seville, Spain. Professor Crespo-Facorro is a world-leading researcher in the area of early psychosis and has been leading one of the first early psychosis intervention program in Spain (PAFIP). Much of his work is aimed at prevention and early intervention of psychotic disorders. He has published over 280 peer-reviewed scientific articles (150 as senior author). His work was awarded with several national and international prizes, including the Banco Sabadell Foundation Biomedical Research Award. Current h index 54.

Associate Editor:

Dra. Analia Bortolozzi Biassoni, MD, PhD
Instituto de Investigaciones Biomédicas de Barcelona (CSIC) - IDIBAPS - CIBERSAM, Barcelona, Spain. Senior Scientific at CSIC and Group Leader of CB/07/09/0034 at the Center for Networked Biomedical Research on Mental Health (CIBERSAM). Her research focuses on study of the neurobiological bases and the treatment of serious mental disorders such as schizophrenia, depression and the latter's comorbidity with Parkinson's disease. Much of her work is aimed at understanding the synaptic disturbances and brain circuits involved in mental disorders using pharmacological and genetic animal models to identify biomarkers and new targets for therapeutic action. She has designed new oligonucleotide-based therapeutic strategies for the treatment of depression and Parkinson's disease. Her research has been funded by the Brain and Behavior Foundation - NARSAD, Michael J Fox Foundation, Instituto de Salud Carlos III and Ministry of Economy and Competitiveness, among others. She has published over 60 papers in peer-reviewed journals, cited ~2.700 times (h = 24; Web of Science). Her work has been awarded with several national and international prizes, including the Pfizer Foundation Award in Basic Research category, the CSIC Award, and the joint recipient of the European College of Neuropsychopharmacology.

Dr. José De León, MD
Professor at the University of Kentucky Department of Psychiatry, Lexington, KY, USA. His most important scientific contributions to the literature include demonstrating: 1) that the association between smoking and schizophrenia is present worldwide, and may be partly explained by shared vulnerability; 2) the association of polydipsia with smoking and schizophrenia in patients with severe mental illness; 3) that CYP3A4 inducers and the CYP2D6 poor metabolizer phenotype may influence risperidone pharmacokinetics and response; 4) valproate's inductive properties for valproate, olanzapine and clozapine metabolism, 5) that a small number of psychiatric patients behave as ultrarapid metabolizers due to genetic or drug-drug interactions, and 6) clozapine metabolism is influenced by ethnicity (Asians have lower ability to metabolize clozapine than Caucasians) and is impaired during pneumonia, which is particularly lethal in clozapine patients. He has published more than 360 peer-reviewed manuscripts described in PubMed. According to ResearchGate in April of 2020, Dr. de Leon's scientific publications have been cited more than 14,000 times, and have had more than 50,000 reads. He has an h-index of 62 (he has at least 62 articles with ≥ 62 citations).

Dr. Emilio Fernández Egea, MD PhD
I'm a clinical academic affiliated to the Department of Psychiatry, University of Cambridge as Associate lecturer and clinically working as consultant psychiatrist to the local mental health services, where I lead the treatment resistant schizophrenia unit. Translating the schizophrenia research into novel clinical care interventions is paramount for me, so I also devote my time to the Comprehensive Research Network NIHR-CRN and the NIHR-HTA funding committee for large UK-based clinical trials. From the research point of view, I initially studied the molecular pathways that links schizophrenia with rest of the body (inflammation, ageing and metabolism) but more recently I moved into exploring factors associated with heterogenity in schizophrenia, particularly the neuroscience of negative symptoms and comorbid obsessive-compulsive disorder. My research has been funded by NARSAD, NIH (RO1), NIHR-BRC, NIHR-HTA and MRC-NIHR, among others.

Dra. Ana Maria González-Pinto Arrillaga, MD, PhD
Professor Ana González-Pinto is the Chair of the Psychiatry Department of the Hospital Universitario de Alava, Spain. She is also Assistant Professor of Psychiatry and Vice-Dean of the Faculty of Medicine of the Basque Country. She is the coordinator of the Bipolar Area of the CIBERSAM (Network Center of Research in Mental Health, Spain). In addition she is Chief of Research of Neurosciences in the BIOARABA Institute of Research, Basque Country. She has also been a member of the Educational Committee of the European College of Neuropsychopharmacology (ECNP). Dr González-Pinto has conducted her research on affective disorders and first psychotic episodes in Madrid, Bilbao, and Vitoria in Spain. She has published more than 200 articles in high impact factor journals. She has received research grant funding from the Horizon 2020, and other European Grants, and also National and Basque Government research grants. Her area of interest are bipolar, affective and psychotic disorders, focused especially in the first stages. Professor Ana González-Pinto is President of the National Society of Biological Psychiatry. She is part of the Board of Councils of the International Society of Bipolar Disorders. And has been President of the Vasco-Navarra Society of Psychiatry. She belongs to Several Editorial Boards of European Journals.

Dr. Javier Labad Arias, M.D., Ph.D.
Javier Labad is a psychiatrist, endocrinologist and master in Statistics. He currently works as the Head of the Adult Psychiatric Hospitalization Unit at Parc Taulí Hospital Universitari (Sabadell, Spain). He also coordinates the Early Intervention Service for Psychosis at the same institution. He is an assistant professor of Psychiatry (accredited as full professor by the AQU) at the Department of Psychiatry and Legal Medicine from the University Autònoma de Barcelona (UAB). His research interests include the study of the role of stress and hormones on the pathogenesis and outcome of mental disorders, with a particular interest on early psychosis. He leads the Research Group in Psychoneuronendocrinology and Stress in Psychosis (2017SGR632). He has authored more than 100 publications with an H-index of 28.

Dr. José Manuel Menchón Magriñá, MD, PhD
Clinical psychiatrist, professor of Psychiatry at the University of Barcelona, Head of the Department of Psychiatry at the Bellvitge University Hospital, Group Leader of the Psychiatry and Mental Health group at the Bellvitge Biomedical Research Institute (IDIBELL) and Head of Research Group at the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM, the official mental health research network in Spain). His research is mainly focused on obsessive-compulsive and related disorders and mood disorders, from a clinical and translational perspective, particularly on treatment outcomes, risk factors and neuroimaging. He has published over 300 papers in scientific peer-reviewed international journals. He is an active member of the main national psychiatric societies, international societies, such as the International College of Obsessive Compulsive Spectrum Disorders (ICOCS), in which he has been former chair and is currently an Associate Director, chair of the Obsessive Compulsive and Related Disorders Network (OCRN) in the European College of Neuropsychopharmacology (ECNP) and participates in several international projects and consortia.

Dra. Mara Parellada Redondo, MD; PhD
Graduated from Medical School Universidad Autónoma, Madrid, Spain, in 1992, became Adult Psychiatrist in December 1997 and Specialist in Child Psychiatry with a Diploma in the Institute of Psychiatry, Kings College, London in 1999. Doctor in Medicine, University Alcala, European Program.
Consultant in Psychiatry at the Hospital Gregorio Marañón in Madrid, at the Department of Child and Adolescent Psychiatry, since 2000. Dr Parellada holds an Assistant Professor Position at the School of Medicine, Universidad Complutense, Madrid and an Associate Visiting Professorship at the University of California in San Francisco, US. She has been conducting research and publishing in the area of first episodes of psychosis since 2003. She is an international trainer in the ADOS-2 since 2013.
Member of the CIBERSAM, Center for the National Research on Mental Health, through the Child and Adolescent Psychiatry Department, Instituto de Investigación Sanitaria Gregorio Marañón, at the HGUGM, in the last 16 years she has been the leader of the autism line of research of the group, to study the biological bases of autism spectrum disorders. This has gone in parallel with the set up and coordination of the first clinic in Spain for medical problems of ASD, AMITEA, where more than 4500 patients have been attended. She has published more than 200 papers in peer-review journals and has been P.I. of several peer-reviewed national and European public- and private-funded grants that study biological basis of autism and the overlap between autism and early-onset schizophrenia.

Dr. Joaquim Radua Castaño, MD, PhD
Leader of the Imaging of Mood- and Anxiety-Related Disorders (IMARD) group at IDIBAPS, Barcelona, and honorary researcher at the Institute of Psychiatry, Psychology & Neuroscience, King's College London, and the Karolinksa Institutet, Stockholm. Dr. Radua is psychiatrist and statistician specialized in mental health research using neuroimaging techniques, meta-analyses and umbrella reviews. One of his methods, Seed-based d Mappin (SDM), is one of the meta-analytic methods for voxel-based studies most used by the scientific community. He is one of the world's most influential scientific minds, according to Clarivate Analytics ranking (Highly Cited Researchers).

Dr. Miguel Ruiz Veguilla, MD, PhD
Miguel Ruiz Veguilla is a Psychiatrist who works as clinician as well as researcher at Hospital Universitario Virgen del Rocío (Sevilla) and Instituto de Biomedicina de Sevilla (IBiS). He has focused his research interests on the ethiopathogenesis of schizophrenia. Additionally, in the last years much of his work aimed at suicide prevetion.

Dra. Pilar Alejandra Saiz Martínez, MD, PhD, Clinical Biochemistry and Psychiatrist
Professor of Psychiatry at the University of Oviedo, Spain, and also member of the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), of the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), and of the Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA). She has been involved in research of bio-psycho-social aspects of suicidal behaviour and major mental disorders for over 25 years and she is co-author of several publications ranging from biological aspects to psycho-social correlates of those disorders. She has recently participated in different multicentre European research projects regarding the prevention and monitorization of suicidal behaviour in Europe (MONSUE Project) and the prevention of suicidality and other risk behaviours in young people, Saving and Empowering Young Lives in Europe - SEYLE Project and Working in Europe to Stop Truancy Among Youth - WE-STAY Project, funded by the EU 7th Framework Programme.

Dr. Eduard Vieta, MD, PhD
Professor of Psychiatry and Chair at the University of Barcelona and Head of the Department of Psychiatry and Psychology at the Hospital Clinic, where he also leads the Bipolar and Depressive Disorders Program in Barcelona, Catalonia, Spain. His unit is one of the worldwide leaders in clinical care, teaching and research on affective disorders. Dr. Vieta is also the current Scientific Director of the Spanish Research Network on Mental Health (CIBERSAM). He has received the Aristotle award (2005), the Mogens Schou award (2007), the Strategic Research award of the Spanish Society of Biological Psychiatry (2009), the Official College of Physicians award to Professional Excellence (2011), the Colvin Price on Outstanding Achievement in Mood Disorders Research by the Brain and Behaviour Research Foundation (2012), the Clinical Neuroscience Lilly award by the International College of Neuropsychopharmacology (CINP 2014), the Simon Bolivar Award (American Psychiatric Association 2017) and the Research Price of the World Federation of Societies of Biological Psychiatry (WFSBP, 2017). He has been named twice best psychiatrist in Spain (Monitor sanitario, El Español), honorary member of the Spanish Society of Biological Psychiatry, and Doctor Honoris Causa by the University of Valencia. He has authored more than 900 original articles, 450 book chapters and 43 books. His h index is 124 and has over 56.000 citations (Google Scholar), which makes him the most cited scientist worldwide in the field of bipolar disorder over the last 8 years and one of the world¿s most influential scientific minds, according to Clarivate Analytics ranking (Highly Cited). His papers have over 600.000 downloads. Furthermore, he is on the editorial board of many scientific journals and has served as invited professor at McLean Hospital and Harvard University and as neuroscience scientific advisor to the European Presidency.

Consultant Board

Dra. Maria del Pino Alonso Ortega, MD, PhD
Department of Psychiatry, Hospital de Bellvitge. Department of Clinical Sciences. Barcelona, Spain

Celso Arango López, MD, PhD
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine. Universidad Complutense de Madrid, Madrid, Spain

Alfonso Araque, MD, PhD
Department of Neuroscience, University of Minnesota, Minneapolis, United States of America

Dra. Rosa Ayesa-Arriola, MD, PhD
Psychiatry Group, Valdecilla Biomedical Research Institute, Santander, Spain

Professor José Luis Ayuso Mateos, MD, PhD
Professor of Psychiatry at the Autonomous University of Madrid and Hospital Universitario de la Princesa, Madrid, Spain

Enrique Baca-García, MD, PhD
Head of the Jimenez Diaz Foundation Psychiatry Department, Rey Juan Carlos University Hospital, Infanta Elena University Hospital, Villalba General Hospital, Professor of Psychiatry. UAM. CIBERSAM, Madrid, Spain

Dra. Vanessa H. Bal, MD, PhD
Karmazin & Lillard Chair for Adult Autism; Associate Professor. Graduate School of Applied & Professional Psychology; Rutgers University ¿ New Brunswick; Piscataway, NJ, New Brunswick, United States of America

Miquel Bernardo, MD, PhD
Professor of Psychiatry. University of Barcelona Senior Consultant Psychiatrist. Hospital Clínic de Barcelona Head Schizophrenia Research Team IDIBAPS. PI CIBERSAM, Barcelona, Spain

Julio Bobes García, MD, PhD
Professor of Psychiatry. University of Oviedo - CIBERSAM, Oviedo, Spain

Paolo Bambrilla, MD, PhD
Director, Psychiatric Clinic, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Associate Professor of Psychiatry, University of Milan, Milan, Italy.Adjunct Associate Professor of Psychiatry, UT Houston Medical School, TX, Milan, USA

Narcis Cardoner, MD, PhD
Head of Mental Health. University Hospital Parc Taulí. Sabadell, Barcelona, Spain. Professor Universitat Autonoma de Barcelona, Sabadell, Spain

André F. Carvalho, MD, PhD
Associate Professor Department of Psychiatry Temerty Medical School, Toronto, Canada

Jorge Cervilla, MD, PhD
Professor of Psychiatry, University of Granada, Granada, Spain

Boris Chaumette, MD, PhD
Université de Paris - Institute of Psychiatry and Neuroscience of Paris (INSERM U1266) - GHU Paris Psychiatrie et Neurosciences, Paris, France. Department of Psychiatry - McGill University, Montreal, Paris, Canada

Francisco Ciruela-Alférez, MD, PhD
Department of Pathology and Experimental Therapeutics, Pharmacology Unit, Faculty of Medicine and Health Sciences, University of Barcelona, L¿Hospitalet de Llobregat, Barcelona, Spain

Christoph U. Correll, MD, PhD
Clinic for Psychiatry, Psychosomatics and Psychotherapy of Children and Adolescents Charité - Universitätsmedizin Berlin, Germany. Professor of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine Hempstead, New York, USA, Berlin Germany

Samuele Cortese, MD, PhD
Professor of Child and Adolescent Psychiatry, University of Southampton, UK. Honorary Consultant Child and Adolescent Psychiatrist, Solent NHS Trust, Southampton, United Kingdom

Philippe Courtet, MD, PhD
Professor of Psychiatry University of Montpellier Department of Emergency Psychiatry and acute care, Academic Hospital of Montpellier, Montpellier, France

Manuel Cuesta Zorita, MD, PhD
Head of the Hospital Complex Psychiatry Service of Navarra, Pamplona, Spain

Paola Dazzan, MD, MSc, PhD, FRCPsych
Professor of Neurobiology of Psychosis, Institute of Psychiatry, Psychology and Neuroscience, King¿s College London, London, United Kingdom

Carlos De las Cuevas-Castresana, MD, PhD
Full Professor of Psychiatry, Department of Internal Medicine, Dermatology and Psychiatry, Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife. Islas Canarias, Spain

Manuel Desco Menéndez, MD, PhD
Department of Bioengineering and Aerospace Engineering. Carlos III University of Madrid. Experimental Medicine and Surgery Unit. Gregorio Marañón University General Hospital, Madrid, Spain

Kim Q. Do, MD, PhD
Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Site de Cery, Prilly-Lausanne, Lausanne, Switzerland

Lourdes Fañanás Saura, MD. PhD, BsC
Full Professor, University of Barcelona. Department of Evolutionary Biology, Ecology and Environmental Sciences (BEECA), Faculty of Biology, Barcelona University, Barcelona, Spain

Miguel Angel Fullana Rivas, MD, PhD
August Pi i Sunyer Biomedical Research Institute (IDIBAPS) & CIBERSAM & Adult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic, Barcelona, Spain

Clemente García Rizo, MD, PhD
Associate Professor University of Barcelona Barcelona Clinic Schizophrenia Unit Neuroscience Institute, Hospital Clinic, Barcelona, Spain

Maria Paz García-Portilla González, MD, PhD
Professor of Psychiatry, University of Oviedo. Centro de Investigación en Red de Salud Mental, CIBERSAM Mental Health Services of Oviedo. Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain

Javier González Maeso, MD, PhD
Professor Department of Physiology and Biophysics, Virginia Commonwealth University, School of Medicine, Richmond, United States of America

Alexandre González Rodríguez, MD, PhD
Senior Psychiatrist.  Associate Lecturer. Department of Mental Health. Parc Taulí University Hospital. I3PT. Autonomous University of Barcelona (UAB). CIBERSAM. Sabadell, Barcelona, Spain

Antoni Gual-Solé, MD, PhD
Head of the Addictions Unit. Psychiatry Department. Neurosciences Institute. Hospital Clínic. IDIBAPS of Barcelona, Barcelona, Spain

Josep María Haro Abad, MD, PhD
Director Teaching Research and Development Parc Sanitari Sant Joan de Déu. Assistant professor University of Barcelona, Barcelona, Spain

Beng C. Ho, MD, PhD
Professor Psychiatry, Department of Psychiatry, University of Iowa, Iowa City, United States of America

Guillermo Horga, MD, PhD
Associate Professor of Psychiatry. Columbia University and New York State Psychiatric Institute. Division of Translational Imaging, New York State, New York, United States of America

Oliver Howes, MD, PhD
Group Head and Professor of Molecular Psychiatry. Consultant Psychiatrist,The Institute of Psychiatry/ Maudsley Hospital, London, United Kingdom

Ángela Ibáñez, MD, PhD
Head of Psychiatry Service Department of Psychiatry Hospital Universitario Ramón y Cajal. Ramón y Cajal Institute for Health Research (IRYCIS). Network Centre for Biomedical Research in Mental Health (CIBERSAM) Universidad de Alcalá, Madrid, Spain

Félix Inchausti, Ph.D, Clin.Psy.D
Department of Mental Healh, Unidad de Salud Mental Espartero. Deparment of Educational Sciences, University of La Rioja, Logrono, Spain

Peter Jones, MD, PhD, FRCPsych, FMedSci
Professor of Psychiatry, University of Cambridge. Hon consultant psychiatrist & non-executive director, Cambridgeshire annd Peterborough NHS Foundation Trust, Cambridge, United Kingdom

Golam M. Khandaker, MD, PhD
Professor of Psychiatry, MRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK. Wellcome Trust Fellow, Department of Psychiatry, University of Cambridge, Bristol, United Kingdom

Tilo Kircher, MD, PhD
Philipps-Universitat MarburgDirektor/ Chair Klinik für Psychiatrie und Psychotherapie, Philipps-Universität Marburg ¿ UKGM, Marburg, Germany

Juan Carlos Leza Cerro, MD, PhD
Professor Department of Pharmacology and Toxicology Faculty of Medicine Complutense University of Madrid, Madrid, Spain

Jorge López-Castroman, MD, PhD
Full professor of psychiatry. CIBERSAM, Spain. University of Montpellier, France. Nimes University Hospital, Montpellier, France

Anabel Martinez-Aran, MD, PhD
Clinical psychologist, Bipolar and Depressive disorders Unit, Hospital Clinic Barcelona, Barcelona University IDIBAPS, CIBERSAM, Barcelona, Spain

José Javier Meana Martínez, MD, PhD
Department of Pharmacology, University of the Basque Country UPV/EHU, and CIBERSAM, Leioa, Bizkaia, Spain

Juan Antonio Micó, MD, PhD
Professor of Pharmacology. Department of Neuroscience (Pharmacology & Psychiatry). Neuropsychopharmacology & Psychobiology Research Group PAIDI-CTS-510 CIBER of Mental Health, CIBERSAM Group G18, Cádiz, Spain

B¿a¿ej Misiak, MD, PhD
Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland

Sven Mueller, MD, PhD
Associate Professor. Department of Experimental Clinical and Health Psychology Ghent University, Gent, Belgium

Andrea Murru, MD, PhD.
Bipolar and Depressive Disorders Unit, IDIBAPS CIBERSAM, Department of Psychiatry, Hospital Clínic de Barcelona, Barcelona, Spain

Juan Nacher, MD, PhD
Full Professor of Cell Biology. Institute for Biotechnology and Biomedicine. Universitat de Valencia, G23 CIBERSAM, Burjasot. Valencia, Spain

Roser Nadal Alemany, MD, PhD
Associate Professor of the University, Institut de Neurociències, Unitat de Psicobiologia (Facultat de Psicologia), (Cerdanyola del Vallès), Barcelona, Spain

Susana Ochoa-Güerre, MD, PhD
Parc Sanitari Sant Joan de Déu. CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain

José Manuel Olivares-Diez, MD, PhD
Head of the Department of Psychiatry, Hospital Alvaro Cunqueiro, Health Area of Vigo. Director, Research Area of Neurosciences, South Galician Health Research Institute, CIBERSAM, Vigo, Spain

Diego Palao, MD, PhD
Full Professor, Executive Director of Mental Health at Corporació Sanitària Parc Taulí, Sabadell, Spain

Victor Pérez Solá, MD, PhD
Institute of Neuropsychiatry and Addictions, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. CIBERSAM, Department of Psychiatry, University Autonoma Barcelona, Barcelona, Spain

Antonio M. Persico, MD, PhD
Full Professor of Child & Adolescent Neuropsychiatry, Director of the Interdepartmental Program "Autism 0-90", University of Messina, Messina, Italy

Edith Pomarol, MD, PhD
FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain and CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental), Madrid, Spain

Josep Antoni Ramos Quiroga, MD, PhD
Head of Department of Psychiatry, Hospital Universitari Vall d¿Hebron. President of Innovation Commission Vall d¿Hebron. Group of Psychiatry, Mental Health and Addiction, Barcelona, Spain

Roberto Rodríguez Jiménez, MD, PhD
Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12). Universidad Complutense de Madrid. CIBERSAM, Madrid, Spain

Adriane R. Rosa, MD, PhD
Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA). Department of Pharmacology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre - RS, Brazil

Dan Rujescu, MD, PhD
Professor Head of Alzheimer Memory Center, Ludwig-Maximilians-University Munich, Munich, Germany

Luís Salvador-Carulla, MD, PhD
Head, Centre for Mental Health Research, Research School of Population Health, ANU College of Health and Medicine, Australian National University, Sydney, Australia

Virginia Soria Tomás, MD, PhD
Department of Psychiatry, Bellvitge University Hospital-Institute of Biomedical Research of Bellvitge (IDIBELL). Department of Clinical Sciences, School of Medicine, Universitat de Barcelona. L'Hospitalet de Llobregat, Barcelona, Spain

Gregory Strauss, PhD
Assistant Professor, Department of Psychology, University of Georgia. Director Clinical Affective Neuroscience Laboratory. Director Georgia Psychiatric Risk Evaluation Program, Georgia, United States of America

John Suckling, MD, PhD
Director of Research in Psychiatric Neuroimaging, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom

Gisela Sugranyes, MD, PhD
Senior Specialist, Department of Child and Adolescent Psychiatry and Psychology, 2017SGR881, Institute of Neuroscience, Hospital Clinic Barcelona. IDIBAPS. CIBERSAM, Barcelona, Spain

Rafael Tabarés-Seisdedos, MD, PhD
Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, School of Medicine, University of Valencia. CIBER of Mental Health (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain

Florence Thibaut, MD, PhD
Department of Psychiatry/Addictology University Hospital Cochin, University of Paris, Paris, France

Gustavo Turecki, MD, PhD
Professor and Chair, Department of Psychiatry, McGill University, Montreal, Canada. Scientific Director Douglas Institute. Psychiatrist-in-Chief CIUSSS ODIM, Montreal, Canada

Olga O, Valverde, MD, PhD
Neurobiology of Behaviour Research Group (Grenec-NeuroBio); Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain

Javier Vázquez-Bourgon, MD, PhD
Psychiatry Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain

Elisabeth Vilella Cuadrada, MD, PhD
Director of the Research Area of Hospital Universitari Institut Pere Mata (HU IPM). Institut d'investigació Sanitària Pere Virgili (IISPV). FMCS, Rovira i Virgili University (URV). CIBERSAM, Reus, Spain